Tech & Venture Briefing — Tuesday 27 October 2026

The TOP 6 Stories

1. Anthropic’s S-1 rolls on
First-half revenue of $16.3bn to 30 June, up from $1.16bn a year earlier, together with a single-share structure that gives the seven co-founders 50.1% of voting power. AIN.Capital reports that the valuation could reach $2 trillion. The prospectus itself is vast. The FT counts roughly 240,000 words setting out the company’s mission, about $800bn of data-centre commitments and what it calls an extraordinary governance structure. The BBC puts it at 355 pages of never-before-disclosed information. The Guardian highlights more than 90 pages of risk factors, from cyber-attacks to the limits of safeguards, set against explosive growth and huge costs.
Why it matters: Every founder will now be asked by their investors which categories Anthropic might enter.
Sources: Tech.eu · The Guardian · FT (1) · FT (2) · FT (3) · BBC News · AIN.Capital

2. London robotics startup Machenta raises a record $40m seed
Machenta, a London robotics startup co-founded by a robotics professor and his student, emerged from stealth with a $40m seed round, which Tech.eu describes as a record. Creandum and Union Square Ventures co-led. The company is building an AI model that it claims has found a new, quick way of teaching robots physical jobs.
Why it matters: Physical-AI startups continue to emerge as a European strength.
Sources: Tech.eu

3. Sequoia and General Catalyst reportedly value an ex-police officer’s AI startup at $400m
The FT reports that Steven Richardson, a former Merseyside police officer, has raised funds from investors including Sequoia for a company providing tools to police forces, at a valuation of $400m. It’s called 22one but not much else is known about it.
Why it matters: It’s probably a play to snatch contracts from Palantir.
Sources: Sifted · FT

4. Nevis raises a $70m (€62m) Series B led by EQT Ventures
London and New York-based Nevis, which calls itself an AI operating system for wealth management, has raised a €62m ($70m) Series B led by EQT Ventures. QuantumLight also backed the round. Total funding now stands at €98m ($110m) in the two years since founding.
Why it matters: One of the largest European rounds of the week, and a sign that agentic AI is entering wealth management.
Sources: EU-Startups · Sifted

5. Vera Health raises a $28.5m Series A led by Threshold Ventures
Vera Health, a clinical AI search engine that claims to reasons like a clinician, has announced a $28.5m Series A led by Threshold Ventures. Participants include Optum Ventures, the healthcare venture arm backed by UnitedHealth Group, Mantis VC and SV Angel. The product helps physicians find and evaluate medical evidence in seconds while presenting its sources clearly. It’s grown from two doctors to 800,000 clinicians.
Why it matters: A strategic arm backed by a major health insurer shows incumbents are concerned and need to get in at the early stage.
Sources: Tech.eu

6. Atlas Bio launches from stealth with $12.5m, led by Creandum
Swiss tech-bio company Atlas Bio has launched from stealth with a $10m seed round led by Creandum, alongside a previously unannounced pre-seed round led by First Momentum Ventures and LEA Partners, bringing total funding to $12.5m. It is developing a foundational AI model to run in silico clinical trials, simulating patient-level efficacy and safety signals before human trials begin. It is tackling drug development’s roughly 70% failure rate and moving beyond animal testing.
Why it matters: Creandum is now the lead investor behind two of this week’s biggest early-stage health/biotech rounds.
Sources: Tech.eu

Tech & Venture Briefing — Tuesday 27 October 2026

The TOP 6 Stories

Other stories worthy of note:

Reply

Keep Reading